While antibiotics given in the first week of life reduce vaccine responses at 15 months, probiotics might counteract these ...

Twelve months after revaccination, antibody levels declined but remained significantly higher than baseline in patients with CLL.

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

The CDC’s ACIP updated guidance on pneumococcal vaccination, recommending a single dose of PCV for all adults aged 50 years and older.

MSD Vietnam, in collaboration with the National Institute for Control of Vaccines and Biologicals, recently organized a ...